Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-rich plasma for repeated implantation failure in women undergoing frozen embryo transfer
IRCT20180417039338N2Phase 2Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Mar 2017
- Countries
- 1
01
Overview
Phase 2, open-label trial of platelet-rich plasma and estradiol in Recurrent Implantation Failure (RIF) and female infertility (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Clinical pregnancy, Ongoing pregnancy and 3 more. Started Mar 2017; status: completed.
02
Drugs
platelet-rich plasmaestradiol
03
Conditions
Recurrent Implantation Failure (RIF)female infertility
Beyond the preview
Go deeper on IRCT20180417039338N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180417039338N2.